@timothyalex
Active 3 days, 17 hours ago-
Timothy Alexander wrote a new post 1 month, 3 weeks ago
AI Engine Promises Buyer Activation in Weeks — pharosIQ Pushes B2B Marketing Forward
PHILADELPHIA, PA — pharosIQ unveiled a major upgrade to its atlasIQ Intelligence Engine, positioning the platform as a high-speed activation tool d […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
Chester County Dojang Shines in High-Stakes New York Taekwondo Championship
CHESTER SPRINGS, PA — Master Son’s Eagle Taekwondo has earned national recognition after delivering a standout performance at the 37th New York Sta […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
Palvella Races Toward Key 2026 Readouts as Rare-Disease Pipeline Expands Rapidly
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) reported third-quarter results and detailed an intensifying slate of clinical milestones as i […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
Passage Bio Pushes Toward Key 2026 Milestones as Gene Therapy Program Accelerates
PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) reported third-quarter financial results and outlined steady progress across its upliFT-D gene t […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
Orchestra BioMed’s Big Cash Infusion Sets Stage for High-Stakes Cardiology Trials
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) reported third-quarter financial results and detailed a series of strategic and r […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
Philly’s Best Unveils Bold Rebrand as It Prepares for Major Expansion
YEADON, PA — Philly’s Best Steak Company is stepping into its next chapter with a sharp new brand identity, renewed messaging, and ambitious exp […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
Mineralys Nears Pivotal FDA Filing as Hypertension Drug Lorundrostat Advances
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) reported third-quarter financial results and said it is preparing to submit a New Drug A […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
New CAR-T Data Could Upend T-Cell Lymphoma Care — Vittoria Prepares First Reveal
PHILADELPHIA, PA — Vittoria Biotherapeutics, Inc. announced it will present interim clinical data from its first-in-human Phase 1 study of VIPER-101, a […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
ArriVent Maps Ambitious 2026 Oncology Push as Firmonertinib Program Gains Steam
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) reported third-quarter financial results and outlined major clinical milestones that p […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
New Cancer Data Hints at a Surgery-Free Future — Verrica’s VP-315 Shows Big Promise
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) unveiled compelling new data from its Phase 2 study of VP-315, a first-in-class o […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
AstraZeneca’s Fasenra Shows Major Breakthrough in Delaying HES Disease Flares
WILMINGTON, DE — AstraZeneca reported statistically significant Phase III results showing that Fasenra (benralizumab) can substantially delay disease w […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
Chemours Posts Solid Q3 as Refrigerants Surge and Other Segments Struggle
WILMINGTON, DE — The Chemours Company delivered a mixed third quarter, with strong refrigerant demand helping offset weakness across its titanium d […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
Qnity Posts Strong Q3 Gains as Newly Independent Chip Supplier Raises 2025 Outlook
WILMINGTON, DE — Qnity Electronics, Inc. (NYSE: Q), newly spun off from DuPont and now a standalone S&P 500 component, reported solid estimated t […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
Trinseo’s Deeper Loss Spurs Aggressive Cuts as Demand Weakens Again
WAYNE, PA — Trinseo (NYSE: TSE) reported another challenging quarter as soft global demand, pricing pressure in Europe, and lower equity income w […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
Breakthrough Liver Drug Shows Powerful Two-Year Gains — But Raises a Critical Warning
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) unveiled new two-year data showing that its flagship therapy Rezdiffra produced s […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
Sallie Mae Awards $500K in New Scholarships as National Scholarship Month Begins
NEWARK, DE — Sallie Mae has named the newest recipients of its Bridging the Dream Scholarship Program, awarding forty high school students and ten g […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
Cabaletta Bio’s Bold Autoimmune Push Raises Big Questions About the Future of CAR T
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) reported third-quarter results and outlined major clinical and regulatory milestones that p […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
RiskStream Partners With Pypestream to Bring AI-Powered Claims and Policy Automation to Insurers
MALVERN, PA — The Institutes RiskStream Collaborative® has formed a strategic partnership with Pypestream to deliver StreamAI—an enterprise-grade AI s […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
Enviri’s Mixed Quarter Sparks Big Questions About Its Turnaround Path
PHILADELPHIA, PA — Enviri Corporation (NYSE: NVRI) reported flat third-quarter revenue and a deeper loss from continuing operations as uneven p […] -
Timothy Alexander wrote a new post 1 month, 3 weeks ago
Utah’s Top Workplaces Program Finds New Home in 2026 Amid Major Publishing Shift
EXTON, PA — Energage has partnered with the publisher of the Salt Lake Business Journal to relaunch Utah’s Top Workplaces program in 2026, marking a s […] - Load More
